|
CHINA BIOLOGICAL RESEARCH
CASE STUDY -
Human Genome Market Study in China
Client Request
-
Find
level of sophistication of BSL-3 Biosafety Labs in China
-
Determine trends of BSL-3 labs in China to study threatening diseases
and bio-hazards such as AIDS, SARS, Anthrax, Avian Flu, Mad Cow
Disease and other China specific bio-hazards
-
Identify process for BSL-3 lab approval in China
-
Ascertain buying preferences for lab design companies, lab construction,
and research equipment
Primary Impact Findings
- China currently
has twenty BSL-3 Biosafety Labs approved to standard GP-19489- 2004
and the new 2008 standard GP-19489-2008 adopted tougher ventilation
standards currently only achieved with imported filtration equipment
- Twenty additional
BSL-3 Biosafety Labs currently involved in approval process with more
lab expansion planned as Chinese government wants lab expansion to
keep pace with expanding GDP in China
- Processes for
BSL-3 lab approval involves the Chinese Environmental Bureau and the
China Lab Certification Committee for the lab and the Ministry of
Health or the Ministry of Agriculture to approve which diseases a
facility can research
- Chinese scientists
demand name brand diagnostic equipment from Europe and the United
States since Chinese research equipment is not globally accepted as
accurate by the scientific community
Primary Impact Recommendation
- Pursue supplying
BSL-3 lab services and equipment in China
- Position heavily
in China regarding supplying BSL-3 labs as Chinese government is heavily
funding 1000 Genomes Project, SARS, Avian Flu, Anthrax, Mad Cow Disease
and some China specific diseases in effort comparable to the "race
to the moon"
Advantage - Our Clients
|
